3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Neoplasms
5
Pain
4
Vomiting
3
Sleep Initiation and Maintenance Disorders
3
Prostatic Neoplasms
3
Nausea
3
Colorectal Neoplasms
3
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Head and Neck Neoplasms
2
Depression
2
Carcinoma, Non-Small-Cell Lung
2
Cancer Pain
2
Anxiety Disorders
2
Acupuncture
2
Xerostomia
1
Urinary Incontinence, Stress
1
Urinary Incontinence
1
Testicular Neoplasms
1
Teratoma
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Radiation Injuries
1
Prostatic Hyperplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Nausea and Vomiting
1
Interventions
Pregabalin
5
Lidocaine
4
Bupivacaine
3
ziconotide
2
Transcranial Magnetic Stimulation
2
Gabapentin
2
Capsaicin
2
Amitriptyline
2
onabotulinum toxin A
1
Yoga
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Thalidomide
1
Telmisartan
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Sodium Chloride
1
Saline Solution
1
Radiofrequency Ablation
1
Paclitaxel
1
Oxycodone
1
Oxaliplatin
1
Manipulation, Osteopathic
1
Low-Level Light Therapy
1
Lidoderm
1
Ketamine
1
KRN 5500
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neuralgia
×
Electroacupuncture
×
Clear all
NCT04917796
2026-01-30
ACT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
255 enrolled